BIOMARIN PHAR. DL-,001

Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange BIOMARIN PHAR. DL-,001 stocks are traded under the ticker BM8.

BIOMARIN PHAR. DL-,001 is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for BIOMARIN PHAR. DL-,001 has a max estimate of 131.54 EUR and a min estimate of 75.17 EUR.

BM8 earnings for the last quarter are 0.20 EUR per share, whereas the estimation was 0.21 EUR resulting in a −5.20% surprise. The estimated earnings for the next quarter are 0.18 EUR per share. See more details about BIOMARIN PHAR. DL-,001 earnings.

BIOMARIN PHAR. DL-,001 revenue for the last quarter amounts to ‪549.93 M‬ EUR despite the estimated figure of ‪571.23 M‬ EUR. In the next quarter revenue is expected to reach ‪578.78 M‬ EUR.

Yes, you can track BIOMARIN PHAR. DL-,001 financials in yearly and quarterly reports right on TradingView.

No, BM8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, BM8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHAR. DL-,001 stock right from TradingView charts — choose your broker and connect to your account.

BM8 reached its all-time high on Aug 5, 2015 with the price of 131.03 EUR, and its all-time low was 57.42 EUR and was reached on Feb 10, 2016.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHAR. DL-,001 on this list?

We've gathered analysts' opinions on BIOMARIN PHAR. DL-,001 future price: according to them, BM8 price has a max estimate of 131.54 EUR and a min estimate of 75.17 EUR. Read a more detailed BIOMARIN PHAR. DL-,001 forecast: see what analysts think of BIOMARIN PHAR. DL-,001 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHAR. DL-,001 EBITDA is ‪270.10 M‬ EUR, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHAR. DL-,001 financial statements.